According to a recent LinkedIn post from Resilience Care, oncology teams at Clinique Belharra within the Ramsay Santé group have been using telemonitoring as part of their daily medical and paramedical practice for several years. The post points to a new standard of care emerging from long-term integration of telemonitoring into care pathways, multidisciplinary collaboration, and patient adoption.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post highlights an interview with oncologist Dr. Philippe Boudier and care-coordination nurse Myriam Esponde, who reportedly describe how the telemonitoring tool fits into day-to-day follow-up and how responsibilities are distributed across the team. The post suggests that these operational changes may affect both patient experience and staff workflows, indicating potential validation of Resilience Care’s model in routine oncology practice.
For investors, this use case may signal growing institutional acceptance of telemonitoring solutions in cancer care, particularly within large private hospital groups like Ramsay Santé. If such integrations scale across additional sites or networks, it could support recurring revenue opportunities, strengthen Resilience Care’s positioning in digital oncology, and potentially increase switching costs for customers.
The emphasis on multidisciplinary organization and sustained deployment also hints at a services and process-integration component beyond pure software licensing. This could translate into deeper client relationships but may also imply higher onboarding and support costs, making execution efficiency a key factor for the company’s profitability profile over time.

